• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种帮助非霍奇金淋巴瘤患者管理其个人护理路径的教育电子工具的开发与评估

Development and Evaluation of an Educational E-Tool to Help Patients With Non-Hodgkin's Lymphoma Manage Their Personal Care Pathway.

作者信息

Stienen Jozette Jc, Ottevanger Petronella B, Wennekes Lianne, Dekker Helena M, van der Maazen Richard Wm, Mandigers Caroline Mpw, van Krieken Johan Hjm, Blijlevens Nicole Ma, Hermens Rosella Pmg

机构信息

Radboud university medical center, Scientific Institute for Quality of Healthcare (IQ healthcare), Nijmegen, Netherlands.

出版信息

JMIR Res Protoc. 2015 Jan 9;4(1):e6. doi: 10.2196/resprot.3407.

DOI:10.2196/resprot.3407
PMID:25575019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4296091/
Abstract

BACKGROUND

An overload of health-related information is available for patients on numerous websites, guidelines, and information leaflets. However, the increasing need for personalized health-related information is currently unmet.

OBJECTIVE

This study evaluates an educational e-tool for patients with non-Hodgkin's lymphoma (NHL) designed to meet patient needs with respect to personalized and complete health-related information provision. The e-tool aims to help NHL patients manage and understand their personal care pathway, by providing them with insight into their own care pathway, the possibility to keep a diary, and structured health-related information.

METHODS

Together with a multidisciplinary NHL expert panel, we developed an e-tool consisting of two sections: (1) a personal section for patients' own care pathway and their experiences, and (2) an informative section including information on NHL. We developed an ideal NHL care pathway based on the available (inter)national guidelines. The ideal care pathway, including date of first consultation, diagnosis, and therapy start, was used to set up the personal care pathway. The informative section was developed in collaboration with the patient association, Hematon. Regarding participants, 14 patients and 6 laymen were asked to evaluate the e-tool. The 24-item questionnaire used discussed issues concerning layout (6 questions), user convenience (3 questions), menu clarity (3 questions), information clarity (5 questions), and general impression (7 questions). In addition, the panel members were asked to give their feedback by email.

RESULTS

A comprehensive overview of diagnostics, treatments, and aftercare can be established by patients completing the questions from the personal section. The informative section consisted of NHL information regarding NHL in general, diagnostics, therapy, aftercare, and waiting times. Regarding participants, 6 patients and 6 laymen completed the questionnaire. Overall, the feedback was positive, with at least 75% satisfaction on each feedback item. Important strengths mentioned were the use of a low health-literacy level, the opportunity to document the personal care pathway and experiences, and the clear overview of the information provided. The added value of the e-tool in general was pointed out as very useful for preparing the consultation with one's doctor and for providing all information on one website, including the opportunity for a personalized care pathway and diary. The majority of the revisions concerned wording and clarity. In addition, more explicit information on immunotherapy, experimental therapy, and psychosocial support was added.

CONCLUSIONS

We have developed a personal care management e-tool for NHL patients. This tool contains a unique way to help patients manage their personal care pathway and give them insight into their NHL by providing health-related information and a personal diary. This evaluation showed that our e-tool meets patients' needs concerning personalized health-related information, which might serve as a good example for other oncologic diseases. Future research should focus on the possible impact of the e-tool on doctor-patient communication during consultations.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70d9/4296091/fd8ae51b4c93/resprot_v4i1e6_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70d9/4296091/50185eef94d5/resprot_v4i1e6_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70d9/4296091/fd8ae51b4c93/resprot_v4i1e6_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70d9/4296091/50185eef94d5/resprot_v4i1e6_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70d9/4296091/fd8ae51b4c93/resprot_v4i1e6_fig2.jpg
摘要

背景

众多网站、指南和信息手册为患者提供了大量与健康相关的信息。然而,目前对个性化健康相关信息日益增长的需求尚未得到满足。

目的

本研究评估一种针对非霍奇金淋巴瘤(NHL)患者的教育电子工具,该工具旨在满足患者对个性化和完整健康相关信息的需求。该电子工具旨在通过为NHL患者提供对自身护理路径的洞察、记日记的可能性以及结构化的健康相关信息,帮助他们管理和理解个人护理路径。

方法

我们与一个多学科NHL专家小组共同开发了一个电子工具,该工具由两个部分组成:(1)一个个人部分,用于记录患者自己的护理路径和经历;(2)一个信息部分,包括有关NHL的信息。我们根据现有的(国际)指南制定了理想的NHL护理路径。理想的护理路径,包括首次咨询日期、诊断和治疗开始日期,用于建立个人护理路径。信息部分是与患者协会Hematon合作开发的。关于参与者,我们邀请了14名患者和6名外行来评估该电子工具。所使用的24项问卷讨论了有关布局(6个问题)、用户便利性(3个问题)、菜单清晰度(3个问题)、信息清晰度(5个问题)和总体印象(7个问题)等问题。此外,还要求小组成员通过电子邮件提供反馈。

结果

患者通过完成个人部分的问题,可以建立起诊断、治疗和后续护理的全面概述。信息部分包括关于NHL的一般信息、诊断、治疗、后续护理和等待时间等方面的内容。关于参与者,6名患者和6名外行完成了问卷。总体而言,反馈是积极的,每个反馈项目的满意度至少为75%。提到的重要优点包括使用低健康素养水平的表述、记录个人护理路径和经历的机会以及所提供信息的清晰概述。该电子工具的总体附加值被指出对与医生的咨询准备以及在一个网站上提供所有信息非常有用,包括提供个性化护理路径和日记的机会。大多数修订涉及措辞和清晰度。此外,还增加了关于免疫疗法、实验性疗法和心理社会支持的更明确信息。

结论

我们为NHL患者开发了一种个人护理管理电子工具。该工具包含一种独特的方式来帮助患者管理个人护理路径,并通过提供健康相关信息和个人日记,使他们对自己的NHL有所了解。本次评估表明,我们的电子工具满足了患者对个性化健康相关信息的需求,这可能为其他肿瘤疾病树立一个良好的典范。未来的研究应关注该电子工具在咨询过程中对医患沟通可能产生的影响。

相似文献

1
Development and Evaluation of an Educational E-Tool to Help Patients With Non-Hodgkin's Lymphoma Manage Their Personal Care Pathway.一种帮助非霍奇金淋巴瘤患者管理其个人护理路径的教育电子工具的开发与评估
JMIR Res Protoc. 2015 Jan 9;4(1):e6. doi: 10.2196/resprot.3407.
2
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.促进和支持社区中患有慢性身体疾病的成年人进行自我管理:对医患互动的有效性和意义的系统评价。
JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001.
3
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.
4
Critical Care Network in the State of Qatar.卡塔尔国重症监护网络。
Qatar Med J. 2019 Nov 7;2019(2):2. doi: 10.5339/qmj.2019.qccc.2. eCollection 2019.
5
How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?“护理路径技术”对卒中护理服务整合的影响是如何衡量的,以及有哪些证据支持其在这方面的有效性?
Int J Evid Based Healthc. 2008 Mar;6(1):78-110. doi: 10.1111/j.1744-1609.2007.00098.x.
6
Patient Insights Into the Design of Technology to Support a Strengths-Based Approach to Health Care.患者对支持基于优势的医疗保健方法的技术设计的见解。
JMIR Res Protoc. 2016 Aug 24;5(3):e175. doi: 10.2196/resprot.5906.
7
Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.碘-131托西莫单抗:(131)I-抗B1抗体、(131)I-托西莫单抗、抗CD20鼠单克隆抗体-I-131、B1、美罗华、(131)I-抗B1抗体、碘-131托西莫单抗、碘-131抗B1抗体、托西莫单抗
BioDrugs. 2003;17(4):290-5. doi: 10.2165/00063030-200317040-00009.
8
Rethinking Giftedness and Gifted Education: A Proposed Direction Forward Based on Psychological Science.重新思考天赋和英才教育:基于心理科学的前进方向建议。
Psychol Sci Public Interest. 2011 Jan;12(1):3-54. doi: 10.1177/1529100611418056.
9
Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.OCRA 方法评估上肢生物力学过载风险的科学基础,作为 ISO 生物力学风险因素标准中的首选方法。
Scand J Work Environ Health. 2018 Jul 1;44(4):436-438. doi: 10.5271/sjweh.3746.
10
Health-related quality of life in early breast cancer.早期乳腺癌患者的健康相关生活质量
Dan Med Bull. 2010 Sep;57(9):B4184.

引用本文的文献

1
A Systematic Review of Decision Aids in Hematologic Malignancies: What Are Currently Available and What Are We Missing?血液系统恶性肿瘤决策辅助工具的系统评价:目前有哪些可用的,我们还缺少哪些?
Oncologist. 2023 Feb 8;28(2):105-115. doi: 10.1093/oncolo/oyac231.
2
Trends and gaps in precision health research: a scoping review.精准健康研究的趋势和差距:范围综述。
BMJ Open. 2021 Oct 25;11(10):e056938. doi: 10.1136/bmjopen-2021-056938.
3
Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant.血液系统恶性肿瘤和造血细胞移植中社会心理护理的未满足需求

本文引用的文献

1
Decision aids for people facing health treatment or screening decisions.为面临健康治疗或筛查决策的人群提供的决策辅助工具。
Cochrane Database Syst Rev. 2014 Jan 28(1):CD001431. doi: 10.1002/14651858.CD001431.pub4.
2
Delivering high-quality care to patients with a non-Hodgkin's lymphoma: barriers perceived by patients and physicians.为非霍奇金淋巴瘤患者提供高质量护理:患者和医生所感知到的障碍。
Neth J Med. 2014 Jan;72(1):41-8.
3
Development and evaluation of a decision aid on mammography screening for women 75 years and older.发展和评估针对 75 岁及以上女性的乳房 X 光筛查决策辅助工具。
Curr Hematol Malig Rep. 2016 Aug;11(4):280-7. doi: 10.1007/s11899-016-0328-z.
4
What is the Profile of Individuals Joining the KNEEguru Online Health Community? A Cross-Sectional Mixed-Methods Study.加入膝关节专家在线健康社区的人群概况是怎样的?一项横断面混合方法研究。
J Med Internet Res. 2016 Apr 18;18(4):e84. doi: 10.2196/jmir.5374.
JAMA Intern Med. 2014 Mar;174(3):417-24. doi: 10.1001/jamainternmed.2013.13639.
4
Involving women in personalised decision-making on mode of delivery after caesarean section: the development and pilot testing of a patient decision aid.让女性参与剖宫产术后分娩方式的个体化决策:患者决策辅助工具的制定和初步测试。
BJOG. 2014 Jan;121(2):202-9. doi: 10.1111/1471-0528.12516.
5
Interactive decision-support tool for risk-based radiation therapy plan comparison for Hodgkin lymphoma.用于霍奇金淋巴瘤的基于风险的放射治疗计划比较的交互式决策支持工具。
Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):433-45. doi: 10.1016/j.ijrobp.2013.10.028. Epub 2013 Dec 7.
6
Usability testing of ANSWER: a web-based methotrexate decision aid for patients with rheumatoid arthritis.ANSWER 的可用性测试:一种基于网络的用于类风湿关节炎患者的甲氨蝶呤决策辅助工具。
BMC Med Inform Decis Mak. 2013 Dec 1;13:131. doi: 10.1186/1472-6947-13-131.
7
A new method for pulmonary nodule detection using decision trees.一种使用决策树进行肺结节检测的新方法。
Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:7355-9. doi: 10.1109/EMBC.2013.6611257.
8
Internet and social media for health-related information and communication in health care: preferences of the Dutch general population.互联网和社交媒体在医疗保健中用于获取健康相关信息及交流:荷兰普通民众的偏好
J Med Internet Res. 2013 Oct 2;15(10):e220. doi: 10.2196/jmir.2607.
9
Parents seeking health-related information on the Internet: cross-sectional study.在互联网上搜索健康相关信息的父母:横断面研究。
J Med Internet Res. 2013 Sep 18;15(9):e204. doi: 10.2196/jmir.2752.
10
The involvement of gynaecological patients in the development of a clinical guideline for resumption of (work) activities in the Netherlands.荷兰妇科患者参与制定恢复(工作)活动的临床指南。
Health Expect. 2015 Oct;18(5):1397-412. doi: 10.1111/hex.12121. Epub 2013 Aug 29.